The Role of Redox‐Regulating Enzymes in Inoperable Breast Cancers Treated with Neoadjuvant Chemotherapy
Nelli Roininen(Oulu University Hospital), Peeter Karihtala(University of Helsinki)
Cited by 6
Related Papers
Mutation of TP53, translocation analysis and immunohistochemical expression of MYC, BCL-2 and BCL-6 in patients with DLBCL treated with R-CHOP
|Scientific Reports|2018|31
Rare missense mutations in <i>RECQL</i> and <i>POLG</i> associate with inherited predisposition to breast cancer
|International Journal of Cancer|2018|19